Zhaoqing Xinghu Pharmaceutical

Guangdong Xinghu Science and Technology, commonly known as Xinghu Pharmaceutical, is a leading Chinese life sciences company specializing in the development and manufacture of biochemicals, pharmaceutical intermediates, and active pharmaceutical ingredients (APIs). Based in Zhaoqing, the company is a global leader in the production of nucleosides and nucleotides, including inosine, guanosine, and adenosine. Its pharmaceutical portfolio includes essential antiviral agents such as ribavirin and adefovir dipivoxil, alongside a wide range of amino acids for medical and nutritional use. The company operates large-scale fermentation and chemical synthesis facilities that comply with international GMP standards. Publicly traded on the Shanghai Stock Exchange, Xinghu Pharmaceutical serves as a critical supplier to the global healthcare, food additive, and animal nutrition industries.